Not 4 months nearly a year. Short interest stays high until sales happen the days of Abstracts moving the price in a meaningful way is over.
6/15/2016 4,478,552 370,020 12.103540
5/31/2016 4,625,048 486,790 9.501115
5/13/2016 4,573,290 398,010 11.490390
4/29/2016 3,836,792 701,020 5.473156
4/15/2016 4,032,906 290,639 13.875997
3/31/2016 4,403,917 432,644 10.179078
3/15/2016 4,497,644 642,034 7.005305
2/29/2016 4,904,895 565,741 8.669860
2/12/2016 4,657,297 813,893 5.722247
1/29/2016 3,959,789 1,968,854 2.011215
1/15/2016 3,523,113 543,218 6.485634
12/31/2015 3,607,062 244,046 14.780255
12/15/2015 3,634,657 299,595 12.131901
11/30/2015 3,810,553 430,073 8.860247
11/13/2015 4,088,615 370,751 11.027927
10/30/2015 4,115,212 485,739 8.472064
10/15/2015 4,345,608 400,397 10.853248
9/30/2015 4,120,917 637,623 6.462937
9/15/2015 3,918,243 421,497 9.296016
8/31/2015 3,393,194 586,441 5.786079
8/14/2015 3,237,325 894,018 3.621096
Pay with what bottle caps? No they whilee dilute the hell out of cheap shares even Insiders stay away from buying their own tainted shares.
Take it close to bond redemption
Then knowingly do a deal that gets squashed
Create panic and low buyout by TS and Insiders
Is it the plan?
Today helps the plan with market conditions as an excuse.
For starters the story of today on Stocktwits. You possess the greatest gift of convenient BS ever known.
June 17 - you said -There might be some tweaking with the new rule but will not delay too long. Probably a week or 2. Now we know clearly how to play the game.
now- Guys..I 'm traveling for a month so I will not be here often. Stay strong. I had said the deal would be done b4 Sept and now b4 Oct.
What do you mean guess! You the man with all those Chinese connections to confirm everything, right?
Any thought to layoffs if the uptake does not produce by end next qtr? Why keep so many on staff if the Oncologist community is not ready for a couple of years. Legit question legit answers...
Very simple with another dilution. You can bet Bridger is fully hedged. The 5 million will only be covered by a dilution not a squeeze, unless the company states a sales ramp. However, since the qtr is pretty much over one would think they would be ecstatic to pre announce such.
In hindsight the pop to $13 was IBB related algo's etc. Now it is back to fundamentals. Forget about short squeeze BS unless there is a surprise in sales. Core positions are at risk of being reduced in value by dilutions no doubt.
heading back down do you see the bands now? You cannot draw a conclusion of a sustained higher move in BB until it pierces the upper band. Trov barely made it halfway there. Testing $4 again this week my play..
I guess this means I am responding to myself. Good article but here is the immediate take away by the Street..
"Tissue biopsies will continue to be the gold standard approach to diagnosing cancer for at least the next couple of years, oncologist Samuel Klempner told Medical Device Daily, but the sensitivity of some of these liquid-based technologies should not be underestimated."